The European Food Safety Authority has given its scientific blessing to a novel food enzyme derived from genetically modified bacteria, potentially opening the door for European food manufacturers to use this ingredient in various products. This decision impacts food producers seeking new processing aids, consumers who will encounter products containing this enzyme, and biotechnology companies developing genetically modified organisms for industrial applications.
This assessment comes from EFSA's Scientific Opinion published on April 1, 2026, specifically from the Panel on Food Contact Materials, Enzymes and Processing Aids (CEP).
This document represents a mandatory scientific safety assessment that must be completed before any novel food enzyme can be authorized for use in the EU. The opinion contains concrete scientific conclusions about the safety of this specific enzyme when used under proposed conditions, including specific maximum usage levels and application areas, rather than vague policy statements.
The policy direction demonstrates a continued commitment to evidence-based food safety regulation while facilitating innovation in food technology. This represents a balance between consumer protection through rigorous safety assessment and business competitiveness by allowing new technologies to enter the market. The approach prioritizes scientific risk assessment over precautionary bans, though maintains strict oversight of genetically modified ingredients.
For food manufacturers, this creates moderate positive impact by providing access to a new processing tool that could improve production efficiency or product quality. For biotechnology companies, this represents a major positive development as it validates their genetic modification technology and creates a pathway to market. For consumers, the impact is minor but positive as it maintains food safety standards while potentially leading to improved products. For anti-GMO advocacy groups, this represents a negative development as it continues the trend of approving genetically modified food ingredients despite public concerns.
This scientific opinion represents a continuation of the EU's food authorization process, with EFSA's assessment now moving to the European Commission and member states for final regulatory decisions. The European Commission will next consider whether to grant formal authorization based on this safety assessment, with potential political debates expected in the Council and Parliament about GMO-derived food ingredients.